Pluri Inc (PLUR)
4.70
-0.36
(-7.11%)
USD |
NASDAQ |
Nov 21, 16:00
4.87
+0.17
(+3.62%)
After-Hours: 20:00
Pluri Gross Profit Margin (Quarterly): 61.35% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 61.35% |
June 30, 2024 | |
March 31, 2024 | |
December 31, 2023 | |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | 95.65% |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 96.00% |
September 30, 2018 |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | 96.00% |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 96.48% |
September 30, 2015 | 96.84% |
June 30, 2015 | 96.81% |
March 31, 2015 | 96.84% |
December 31, 2014 | 95.79% |
September 30, 2014 | 96.84% |
June 30, 2014 | 97.87% |
March 31, 2014 | 96.84% |
December 31, 2013 | 96.84% |
September 30, 2013 | 96.84% |
June 30, 2013 | 97.89% |
March 31, 2013 | 96.91% |
December 31, 2012 | 96.92% |
September 30, 2012 | 96.92% |
June 30, 2012 | 97.03% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
61.35%
Minimum
Sep 2024
95.65%
Maximum
Dec 2019
78.50%
Average
78.50%
Median
Gross Profit Margin (Quarterly) Benchmarks
InspireMD Inc | 22.87% |
IDenta Corp | 73.37% |
BiomX Inc | -- |
IR-Med Inc | -- |
Raphael Pharmaceutical Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -438.8% |
Return on Assets | -55.22% |
Return on Invested Capital | -74.75% |
Profit Margin (Quarterly) | -1.80K% |
Operating Margin (Quarterly) | -1.59K% |
Return on Net Operating Assets | -275.0% |